A retrospective study evaluating predictive role of viral load at week 4 during eight week course of hepatitis C treatment with ledipasvir-sofosbuvir in treatment naive patients with genotype 1 infection without cirrhosis.

Trial Profile

A retrospective study evaluating predictive role of viral load at week 4 during eight week course of hepatitis C treatment with ledipasvir-sofosbuvir in treatment naive patients with genotype 1 infection without cirrhosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Dec 2016

At a glance

  • Drugs Ledipasvir/sofosbuvir (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Dec 2016 New trial record
    • 30 Oct 2016 Results presented at the IDWeek 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top